Target 3.b. Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines forall. Indicator 3.b.1. Proportion of the target population covered by all vaccines included in their national programme

Proporción de la población vacunada contra Tetanos por comunidades autonomas.

Units:Porcentaje
  • Select values to consult
    • Selected:1
      Total:14
  • Choose format of the table
      • Periodo
      • Autonomous Communities and Cities
      . . .
      . . .
      . . .
  • Notes
    • 1) Las coberturas superiores al 100% se deben a la inclusión en el numerador de niños vacunados que no estan incluidos en la población objeto
      Asturias (2016)* - Coberturas de 2015 (provisionales)
      Cataluña (2013-2014)* - Datos Historia Clinica Informatizada de AP del Institut Català de la Salut (aprox 80% población)
      Baleares (2012)* - Coberturas de 2011
      Baleares (2015)** - Coberturas de 2014
      Baleares (2016)*** - Coberturas de 2014
      País Vasco (2016)* - Datos provisionales
Total: 0seriesy 0cells
  • Source:Ministerio de Sanidad